Sunday, February 21, 2010

Fruits and Veggies May Improve Lung Function in COPD

From Reuters Health Information CME

News Author: Karla Gale
CME Author: Désirée Lie, MD, MSEd

CME/CE Released: 02/19/2010

February 19, 2010 — A diet rich in raw fresh fruits, fruit juices, and vegetables may improve lung function and reduce exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to a prospective randomized trial from Greece.

"There is increasing evidence that COPD is characterized by increased airway and systemic inflammation, which partially is triggered by the aggravated oxidative stress that is prevalent in COPD patients," the authors write in an article published online February 11 in the European Respiratory Journal.

They theorized that balancing oxidative stress through dietary intervention might help protect the lungs in COPD.

Dr. Demosthenes Makris and co-authors at the University of Thessaly School of Medicine, Larissa, enrolled 120 patients with COPD (mean age 68 years; 88% men) in a 3-year open-label study. All patients completed dietary questionnaires at 6-month intervals.

Sixty patients were randomized to the intervention arm, in which they were instructed to increase their fresh fruit and vegetable consumption by at least one portion per day. In the control group, diet was not discussed.

The groups were similar at baseline in demographic factors, smoking or smoking cessation, dietary habits, and spirometry results. They were also similar in terms of physical activity, changes in body mass index, or alcohol consumption during the study.

At baseline, groups were similar in their consumption of vegetables and fruits, the report indicates. Throughout the study, diets in the control group remained unchanged, but antioxidant consumption rose significantly in the intervention group (p = 0.001).

In the year before the study, mean annual exacerbation rates were similar in the intervention group (0.45) and control group (0.51, p = 0.01). During the study, however, mean annual rates were significantly lower in the intervention group (0.18 vs 0.34, p = 0.001).

The high-antioxidant diet was also associated with an annual increase in forced expiratory volume in 1 second (FEV1), whereas mean FEV1 decreased in the control group (p = 0.03). Forced vital capacity was also significantly higher at the end of the study in the intervention group.

The authors report that the association of excess antioxidant consumption with the improvement in FEV1 was significant (p <>

Dr. Makris and his colleagues point out that they did not measure oxidative stress objectively during the study, and they assessed exacerbations simply by questioning the subjects.

Still, they say, "Our findings suggest that a dietary (change) to higher antioxidant foods intake may be associated with improvement in lung function."

"The place of dietary interventions in the management of COPD warrants consideration," the researchers conclude.

Eur Respir J. 2010.

Additional Resource

More information on COPD is available on the National Heart Lung and Blood Institute's Web site.

Clinical Context

Consumption of foods rich in antioxidants may be beneficial to lung function in patients with COPD because antioxidants may protect against oxidative damage to lung tissue and prevent damage from smoking and air pollution.

This is an open-label randomized clinical trial of patients with COPD to examine the association between increased antioxidant intake through fruit and vegetable consumption and lung function assessed by FEV1 during 3 years of follow-up.

Study Highlights

  • Included were patients attending a community primary care clinic in a rural area of Greece who were diagnosed with COPD by the GOLD criteria based on medical history, physical signs, and lung function tests and who were free of COPD exacerbation for at least 4 weeks.
  • Excluded were patients with favorable response to bronchodilators, history of asthma, atopy, and allergic rhinitis or continuous use of systemic corticosteroids for 30 days or more.
  • Following a recruitment period of 2 months, there was a run-in followed by outpatient visits every 6 months for lung function assessment.
  • 120 eligible patients were randomly assigned to a diet rich in fruits and vegetables (n = 60) or usual diet (n = 60).
  • At baseline, all patients underwent physical examination, had BMI and lung function assessed, and had their comorbidities assessed using the Charlson index.
  • Every 6 months during the study, lung function was assessed by spirometry after premedication with 200 μg salbutamol via metered dose inhaler.
  • Food intake was assessed using a food questionnaire modified for antioxidant intake and adjusted for the rural diet in this region, with questions for 38 different food items such as salads and raw vegetables, fresh fruits, and pure fruit juices.
  • 5 categories of frequency of intake, from once or more than once daily to less than once weekly or none, were used.
  • An overall fresh fruits and vegetables score was computed.
  • Intake of cereals, meats, and fish was also reported.
  • The intervention group was counseled to add at least 1 portion of fruits or vegetables to the baseline consumption level at each outpatient visit.
  • The control group received no dietary advice.
  • Both groups received similar COPD care and medications and management of exacerbations by standard clinical guidelines.
  • Participants were not blinded, but assessors of lung function were blinded to assignment.
  • Primary outcome was change in FEV1 after bronchodilator administration compared with baseline.
  • Other outcomes such as quality of life and perceived symptomatology were not reported.
  • Mean age was 68 years, most participants were white, 87.5% were men, and 47% had cardiovascular problems.
  • By GOLD criteria, 18.5% were in stage I, 65.8% in stage II, 12.5% in stage III, and 3.3% in stage IV COPD.
  • During the study, 19.1% stopped smoking, with no difference in quit rate between the 2 groups.
  • Participants attended 794 of 840 follow-up visits, with no differences between the 2 groups.
  • The intervention group consumed significantly more fruits and vegetables than the control group.
  • The mean annual exacerbation rates were 0.45 and 0.51 in the intervention and control groups, respectively.
  • During the study, the mean annual exacerbation rates were 0.18 and 0.34, respectively (both significantly lower than baseline).
  • The difference in exacerbations between the 2 groups was significant.
  • The mean annual change in FEV1 was 0.35 overall for both groups.
  • There was a significant association between increased consumption of fruits and vegetables and change in FEV1.
  • FEV1 improved in the intervention group while worsening in the control group.
  • This improvement was seen for all types of fruits and vegetables.
  • The improvement remained significant after controlling for sex, age, smoking status, comorbidities, and exacerbations.
  • Meat consumption was reduced in the intervention group (1.90 servings per day at baseline vs 1.7 servings per day), but this was not statistically significant.
  • There was no change in meat consumption in the control group.
  • The authors concluded that a diet rich in fruits and vegetables had the potential to improve lung function in patients with COPD.

Clinical Implications

  • Increased consumption of fruits and vegetables in patients with COPD is associated with improved FEV1 and reduced exacerbations during 3 years of follow-up.
  • Increased consumption of fruits and vegetables by 1 serving daily is not associated with significant reduction in meat intake.

Friday, February 5, 2010

DRUG FEVER

Ruchi A. Patel, Pharm.D.; Jason C. Gallagher, Pharm.D.

Posted: 01/26/2010; Pharmacotherapy. 2010;30(1):57-69. © 2010 Pharmacotherapy Publications

Abstract

Drug fever is a common condition that is frequently misdiagnosed. It is a febrile response that coincides temporally with the administration of a drug and disappears after discontinuation of the offending agent. Drug fever is usually suspected when no other cause for the fever can be elucidated, sometimes after antimicrobial therapy has already been started. In nonsensitized individuals receiving a drug for the first time, the onset of fever is highly variable and differs among drug classes, but most commonly appears after 7–10 days of drug administration and rapidly reverses after discontinuation of the drug. Early diagnosis may reduce inappropriate and potentially harmful and expensive diagnostic and therapeutic interventions. Rechallenge with the offending agent will usually cause recurrence of fever within a few hours, confirming the diagnosis. Rechallenge is controversial and should be performed with extreme caution, since there is a potential for a more severe drug reaction. We describe the mechanisms in the pathophysiology of drug fever and summarize the results of published case reports on the wide variety of agents that are implicated in causing drug fever. Special attention is paid to the role of antimicrobial agents in drug fever.

Introduction

Drug fever is a common condition that manifests with an often unclear diagnosis.[1, 2] It is important for clinicians to suspect drugs as a cause of fevers of unknown origin.[1] Since a common response among clinicians to a patient's fever is to suspect infection, drug fever can lead to overutilization of antiinfectives and other agents to treat infections that are not present, possibly increasing the risk of adverse effects and the further development of antimicrobial resistance.[1] Fever that is due to a drug is also significant in that it may precede or accompany more serious adverse drug reactions.[3, 4] Drug fever is particularly problematic when it occurs during the course of an infection, since it can mislead clinicians into believing that a successful course of therapy is failing.

To gain a better understanding of the diagnosis, mechanisms, and management of drug fever so that we could increase awareness among clinicians, we conducted a literature search using the MEDLINE database (1950–2009). Search terms were drug fever, hypersensitivity reactions, drug-induced fever, and drug reactions. References in review articles were also evaluated.



Prevention of Aspirin-Related Gastric Ulcers

From AccessMedicine from McGraw-Hill

Kurt J. Isselbacher

Posted: 01/28/2010; AccessMedicine from McGraw-Hill © 2010 The McGraw-Hill Companies


The use of low-dose aspirin in the prevention of cardiovascular disease is frequently associated with a development of dyspeptic symptoms and erosions or ulcerations in the upper GI tract. Eradication of Helicobacter pylori and maintenance therapy with proton pump inhibitors (PPIs) are effective in the prevention of aspirin-induced GI lesions. The potential role of H2-receptor antagonists after the healing of aspirin-induced ulcers or erosions is unclear.

Ng and colleagues (2010) have reported the results of a randomized, double-blind, controlled study comparing the efficacy of high-dose famotidine with that of pantoprazole in the prevention of recurrent dyspeptic/complicated ulcer or erosions in patients taking low-dose aspirin. Consecutive patients at a center in Hong Kong with a history of aspirin-related peptic disease with or without a history of bleeding were randomized to receive 80 mg of aspirin, with either 40 mg of famotidine or 20 mg of pantoprazole daily for 48 weeks. The endpoints were the presence of ulcer complications and the severity of ulcer complications. Those patients with peptic ulcerations received a healing dose of PPI for 8 weeks while those who were H. pylori positive received an initial 7-day standard PPI-based triple therapy followed by 7 weeks of PPI therapy alone.

Of a total of 161 patients who were randomized, 65 in each arm completed the study. The prevalence of significant dyspepsia or peptic ulceration was significantly higher in the famotidine group compared with the pantoprazole group (20% vs. 0%; p < .0001).

These findings demonstrate that high-dose famotidine therapy is inferior to PPI therapy in preventing recurrence of aspirin-related peptic ulcers or erosions. Thus, PPIs rather than H2-receptor antagonists are recommended in the prevention of recurrent low-dose aspirin–induced upper GI injury.

References

  1. Ng F-H et al: Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions. Gastroenterology 138:82, 2010

Authors and Disclosures

Author(s)

Kurt J. Isselbacher

Distinguished Mallinckrodt Professor of Medicine, Harvard Medical School; Physician and Director, Massachusetts General Hospital Cancer Center, Boston